An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia

Published:2020-02-08 Issue:5 Volume:21 Page:531-539
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Strilchuk Larysa¹,Tocci Giuliano²³^ORCID,Fogacci Federica⁴^ORCID,Cicero Arrigo F. G.⁴^ORCID

Affiliation:

1. Department of Therapy and Medical Diagnostics, Lviv National Medical University, Lviv, Ukraine

2. Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant’Andrea Hospital, Rome, Italy

3. Cardiology Unit, IRCCS Neuromed, Pozzilli, Italy

4. Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy

Funder

was not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1714028

Reference98 articles.

1. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering

2. Risk Assessment Chart for Death From Cardiovascular Disease Based on a 19-Year Follow-up Study of a Japanese Representative Population NIPPON DATA80

3. Practical Risk Prediction Tools for Coronary Heart Disease in Mild to Moderate Hypercholesterolemia in Japan Originated From the MEGA Study Data

4. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

5. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk;Journal of Clinical Medicine;2024-03-25

2. Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?;Pharmaceutics;2024-03-24

3. The impact of early in-hospital use of PCSK9 inhibitors on cardiovascular outcomes in acute coronary syndrome patients: A systematic review and meta-analysis;International Journal of Cardiology;2024-03

4. Are We Using Ezetimibe As Much As We Should?;Biomarker Insights;2024-01

5. Crystal structure of mRNA cap (guanine-N7) methyltransferase E12 subunit from monkeypox virus and discovery of its inhibitors;International Journal of Biological Macromolecules;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3